# Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed

> **NCT00002583** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 482 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** cisplatin
- **DRUG:** vinorelbine ditartrate

## Key facts

- **NCT ID:** NCT00002583
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-07-07
- **Primary completion:** 2004-04-25
- **Final completion:** 2009-12-21
- **Target enrollment:** 482 (ACTUAL)
- **Last updated:** 2020-04-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002583, "Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00002583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*